XML 20 R7.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Millions
Total
Noncumulative Preferred Stock
Cumulative adjustment for adoption of amendment
Preferred Stock
Preferred Stock
Noncumulative Preferred Stock
Common Stock
Additional Paid-in Capital
Retained Earnings
Retained Earnings
Cumulative adjustment for adoption of amendment
Accumulated Other Comprehensive Income (Loss)
Total SVBFG Stockholders’ Equity
Total SVBFG Stockholders’ Equity
Noncumulative Preferred Stock
Total SVBFG Stockholders’ Equity
Cumulative adjustment for adoption of amendment
Noncontrolling Interests
Balance, beginning of period, net of tax at Dec. 31, 2019 $ 6,622     $ 340   $ 0 $ 1,470 $ 4,576   $ 85 $ 6,471     $ 151
Balance, beginning of period, net of tax (Accounting Standards Update 2017-08) at Dec. 31, 2019 [1]     $ (35)           $ (35)       $ (35)  
Balance (in shares) at Dec. 31, 2019           51,655,607                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Common stock issued under share-based and employee benefit plans, net (in shares)           477,079                
Common stock issued under share-based and employee benefit plans, net 31         $ 0 31       31      
Net income 1,294             1,208     1,208     86
Capital calls and distributions, net (24)                         (24)
Other comprehensive income (loss), net of tax 538                 538 538      
Share-based compensation, net 84           84       84      
Common stock repurchases (in shares)           (244,223)                
Common stock repurchases (60)         $ 0   (60)     (60)      
Dividends on preferred stock (17)             (17)     (17)      
Balance, end of period, net of tax at Dec. 31, 2020 8,433     340   $ 0 1,585 5,672   623 8,220     213
Balance (in shares) at Dec. 31, 2020           51,888,463                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Common stock issued under share-based and employee benefit plans, net (in shares)           445,025                
Common stock issued under share-based and employee benefit plans, net 11         $ 0 11       11      
Issuance of stock (in shares)           4,527,000                
Issuance of stock 2,363 $ 3,306     $ 3,306   2,363       2,363 $ 3,306    
Issuance of common stock for the acquisition of Boston Private (in shares)           1,887,981                
Issuance of common stock for the acquisition of Boston Private 1,060         $ 0 1,060       1,060      
Net income 2,073             1,833     1,833     240
Capital calls and distributions, net (80)                         (80)
Other comprehensive income (loss), net of tax (632)                 (632) (632)      
Share-based compensation, net 138           138       138      
Dividends on preferred stock (63)             (63)     (63)      
Balance, end of period, net of tax at Dec. 31, 2021 16,609     3,646   $ 0 5,157 7,442   (9) 16,236     373
Balance (in shares) at Dec. 31, 2021           58,748,469                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Common stock issued under share-based and employee benefit plans, net (in shares)           423,414                
Common stock issued under share-based and employee benefit plans, net (22)         $ 0 (22)       (22)      
Net income 1,609             1,672     1,672     (63)
Capital calls and distributions, net (19)                         (19)
Other comprehensive income (loss), net of tax (1,902)                 (1,902) (1,902)      
Share-based compensation, net 183           183       183      
Dividends on preferred stock (163)             (163)     (163)      
Balance, end of period, net of tax at Dec. 31, 2022 $ 16,295     $ 3,646   $ 0 $ 5,318 $ 8,951   $ (1,911) $ 16,004     $ 291
Balance (in shares) at Dec. 31, 2022           59,171,883                
[1] See Note 2- "Summary of Significant Accounting Policies" for additional details.